Skip to main content
Atrás
CBT logo

Cabot Corporation

Calidad de datos: 100%
CBT
NYSE Basic Materials Chemicals - Specialty
$68.46
▲ $0.64 (0.94%)
Cap. Mercado: 3.58B
Rango del Día
$68.39 $70.54
Rango de 52 Semanas
$58.33 $84.54
Volumen
292,116
Promedio 50D / 200D
$72.82 / $72.63
Cierre Anterior
$67.82

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Basic Materials (467 pares)

Métrica Acción Mediana del Sector
P/E 10.8 2.3
P/B 2.3 1.7
ROE % 22.3 5.9
Net Margin % 8.9 5.3
Rev Growth 5Y % 2.2 4.8
D/E 0.8 0.4

Precio Objetivo de Analistas

Hold
$78.00 +13.9%
Low: $74.00 High: $85.00
P/E Futuro
11.0
EPS Futuro
$6.23
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
3.5 B

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2029 $8.70
$8.51 – $8.92
 4.1 B 1
FY2028 $7.54
$7.37 – $7.73
 3.8 B 2
FY2027 $6.86
$6.74 – $6.94
 3.6 B 4

Puntos Clave

Revenue grew 2.16% annually over 5 years — modest growth
Earnings declined -12.89% over the past year
ROE of 22.25% indicates high profitability
Generating 391.00M in free cash flow
P/E of 10.80 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 9.20%

Crecimiento

Revenue Growth (5Y)
2.16%
Revenue (1Y)-7.04%
Earnings (1Y)-12.89%
FCF Growth (3Y)5.54%

Calidad

Return on Equity
22.25%
ROIC16.84%
Net Margin8.91%
Op. Margin16.73%

Seguridad

Debt / Equity
0.78
Current Ratio1.61
Interest Coverage8.17

Valoración

P/E Ratio
10.80
P/B Ratio2.31
EV/EBITDA7.30
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -7.04% Revenue Growth (3Y) -2.81%
Earnings Growth (1Y) -12.89% Earnings Growth (3Y) -13.75%
Revenue Growth (5Y) 2.16% Earnings Growth (5Y) 7.27%
Profitability
Revenue (TTM) 3.71B Net Income (TTM) 331.00M
ROE 22.25% ROA 8.68%
Gross Margin 25.32% Operating Margin 16.73%
Net Margin 8.91% Free Cash Flow (TTM) 391.00M
ROIC 16.84% FCF Growth (3Y) 5.54%
Safety
Debt / Equity 0.78 Current Ratio 1.61
Interest Coverage 8.17 Dividend Yield 0.02%
Valuation
P/E Ratio 10.80 P/B Ratio 2.31
P/S Ratio 0.96 PEG Ratio -1.16
EV/EBITDA 7.30 Dividend Yield 0.02%
Market Cap 3.58B Enterprise Value 4.53B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.71B 3.99B 3.93B 4.32B 3.41B
Net Income 331.00M 380.00M 445.00M 209.00M 250.00M
EPS (Diluted) 6.02 6.72 7.73 3.62 4.34
Gross Profit 940.00M 960.00M 839.00M 885.00M 799.00M
Operating Income 621.00M 614.00M 526.00M 389.00M 454.00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.82B 3.74B 3.60B 3.53B 3.31B
Total Liabilities 2.11B 2.15B 2.20B 2.49B 2.22B
Shareholders' Equity 1.55B 1.43B 1.26B 898.00M 947.00M
Total Debt 1.22B 1.33B 1.36B 1.53B 1.25B
Cash & Equivalents 258.00M 223.00M 238.00M 206.00M 168.00M
Current Assets 1.54B 1.61B 1.63B 1.82B 1.43B
Current Liabilities 957.00M 772.00M 822.00M 1.11B 1.15B

Puntuaciones de Estrategias

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Contrarian Investing (David Dreman)
#423 of 658
19

Actividad Reciente

Entró Contrarian Investing (David Dreman)
Mar 24, 2026